The effects of chronic carvedilol therapy on QT dispersion in patients with congestive heart failure

European Journal of Heart Failure

Volumn 3, Issue 6, 2001, Pages 717-721

  Yildirir, A ^a   Sade, E ^a   Tokgozoglu, L ^a   Oto, A ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Carvedilol; Congestive heart failure; QT dispersion

Indexed keywords

CARVEDILOL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; DRUG EFFECT; ELECTROCARDIOGRAM; FEMALE; HEART RATE; HEART REPOLARIZATION; HUMAN; MALE; MAXIMUM TOLERATED DOSE; MORTALITY; PRIORITY JOURNAL; QT INTERVAL; SUDDEN DEATH;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; CARBAZOLES; CARDIOMYOPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PROPANOLAMINES; TIME FACTORS; TREATMENT OUTCOME; TURKEY;

EID: 0035204443     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(01)00191-X     Document Type: Article

References (30)

1. Should asymptomatic ventricular arrhythmias in patients with congestive heart failure be treated with antiarrythmic drugs?
2. Congestive heart failure and arrhythmias: An overview
3. Why patients with congestive heart failure die: Arrhythmias and sudden cardiac death
4. Development of arrhythmias in the patient with congestive heart failure: Pathophysiology, prevalence and prognosis
5. The effect of carvedilol on morbidity and mortality in patients with congestive heart failure
6. Nonuniform recovery of excitability in the left ventricle
7. Characteristics and possible mechanisms of ventricular arrhythmia dependent on the dispersion of action potential duration
8. QT dispersion in patients with chronic heart failure: Beta blockers are associated with a reduction in QT dispersion
9. Can drug effects on mortality in heart failure be predicted by any surrogate marker?
10. QT dispersion and sudden unexpected death in chronic heart failure
11. Repolarization dispersion and sudden cardiac death in patients with impaired left ventricular function
12. Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden cardiac death
13. Prognostic value of arrhythmogenic markers in systemic hypertension
14. QT dispersion
15. Mechanism of ventricular arrhythmias caused by increased dispersion of repolarization
16. Cellular electrophysiological changes during ischemia in isolated coronary-perfused cat ventricle with healed myocardial infarction
17. Carvedilol reduces QT interval dispersion in patients with chronic heart failure
18. Sympathetic nervous system
19. QT dispersion is related to autonomic tone in patients with chronic stable heart failure
20. Enalapril reduces QT dispersion in patients with mild congestive heart failure secondary to coronary artery disease
21. Ramipril reduces QT dispersion in patients with acute myocardial infarction and heart failure
22. Long-term beta-blocker therapy improves autonomic nervous regulation in advanced congestive heart failure: A longitudinal heart rate variability study
23. Pre-clinical and clinical pharmacology of carvedilol
24. Changes in plasma endothelin-1 levels reflect clinical response to beta blockade in chronic heart failure
25. Effectiveness of three different doses of carvedilol for exertional angina
26. Cardioprotective effects of carvedilol a new beta-adrenoreceptor antagonist with vasodilating properties, in anesthetized minipigs
27. Carvedilol, a new beta-adrenoreceptor antagonist and vasodilator antihypertensive drug, inhibits superoxide release from human neutrophils
28. Apoptosis and the heart
29. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease
30. Effect of selective versus nonselective beta blockade on QT dispersion in patients with nonischemic dilated cardiomyopathy